ABSTRACT
Background Few studies have assessed the relationship between diabetes and cognitive health outside of high-income countries. We described this relationship in India, a middle-income country of 1.4 billion people.
Methods Data were analyzed from 58,027 adults aged ≥45 years in the baseline wave of the nationally representative Longitudinal Aging Study in India, from 2017 to 2019. Outcomes were scaled cognitive scores (mean of 0 and standard deviation [SD] of 1) and cognitive impairment, defined as a cognitive score 1.5 standard deviations or below the age- and education-matched mean. Diabetes was defined as a self-report of a prior diabetes diagnosis made by a health professional or having a measured hemoglobin A1c ≥6.5% at the time of the LASI survey. To describe the cross-sectional relationship between cognitive health and diabetes, we constructed survey-weighted multivariable linear and logistic regression models controlling for prespecified covariates, including age, sex, sociodemographic characteristics, and rural versus urban residence.
Results In age- and sex-adjusted models, people with diabetes had cognitive scores that were 0.25 SD higher (95% CI: 0.23 to 0.27) and had a 1.3% (95% CI: 0.7 to 1.8) lower prevalence of cognitive impairment than people without diabetes. Differences persisted even when adjusting for demographic, socioeconomic, and geographic characteristics. Rural versus urban residence modified the relationships of diabetes with cognitive score (P = 0.001) and cognitive impairment (P = 0.004). In fully adjusted models, rural respondents with diabetes had 0.05 SD (95% CI: 0.03 to 0.07) greater cognitive scores and 1.7% (95% CI: 0.9 to 2.5) lower prevalence of cognitive impairment than those without diabetes. In urban areas, respondents with and without diabetes had similar cognitive scores and prevalence of cognitive impairment.
Conclusion Urban-rural health differences, the nutrition transition, and social conditions likely influence the observed cross-sectional relationship between diabetes and cognitive dysfunction in India, leading to different associations than previously reported in many high-income countries.
Funding National Institutes of Health, USA and the Ministry and of Health and Family Welfare, Government of India
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://www.iipsindia.ac.in/lasi
Funding Statement
LASI data collection was funded by the National Institute on Aging, National Institutes of Health (NIA/NIH), U.S.A. (R01AG042778); the Ministry of Health and Family Welfare, Government of India (T22011/02/2015-NCD). The NIA/NIH provided funding for a nationally representative sample, drawing samples from the 15 largest states. The Government of India provided additional funding to make the study representative of each state and union territory and enable oversampling of older adults and four metropolitan cities. LASI data processing was funded by the National Institute on Aging, National Institutes of Health (NIA/NIH) (R01AG030153). LASI-DAD data collection was funded by the National Institute on Aging, National Institutes of Health (NIA/NIH), U.S.A. (R01AG051125, U01AG065958). The preparation of this paper was supported by the NIA/NIH (RF1AG055273) and by the National Heart, Lung, And Blood Institute of the NIH under Award Number K23HL161271. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of the University of Southern California (UP-CG-14_00005), the Harvard University IRB (CR-16715-10), the International Institute for Population Sciences (Sr. No. 12/1054), and the Indian Council of Medical Research (F.No.T.21012/07/ 2012-NCD) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
LASI data used in this study, with the exception of DBS biomarkers, are publicly available on the websites of the Gateway to Global Aging (https://g2aging.org/) and International Institute for Population Sciences (IIPS; https://www.iipsindia.ac.in/content/LASI-data). DBS biomarkers will be made public after data are approved for release by the Ministry of Health and Family Welfare, Government of India. To access data, users must register, provide an email address, and sign a data use agreement.